# Springbuk

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/springbuk

- Industry: Software
- Headquarters: Indianapolis, US
- Website: www.springbuk.com
- Total disclosed funding: $24M
- Latest round: Series B (Jan 22, 2018)
- Investors on record: 4

## About

Springbuk, Inc. specializes in health data analytics, providing organizations with actionable insights to optimize employee benefits and healthcare strategies through its advanced analytics platform.Founded in 2015 and headquartered in Indianapolis, US, Springbuk, Inc. focuses on delivering health data analytics solutions for employee benefits leaders. The company's leadership includes CEO Rod Reasen, who, alongside co-founders Phil Daniels and Rod Reasen, has contributed to its strategic direction. Springbuk has successfully raised USD 17.00 mn in its most recent funding round in August 2019, which was part of a total funding of USD 17.00 mn across 5 deals.Springbuk's primary offering is its health data analytics platform tailored for employee benefits leaders. This platform combines clinical expertise with advanced data analytics to provide insights that aid organizations in evaluating strategies and managing employee healthcare costs. The company addresses cost-saving opportunities and health risks within employee populations, serving clients that include employers, benefits advisors, and vendors across multiple industries throughout the US and beyond.Springbuk operates on a subscription-based revenue model, catering to businesses seeking comprehensive health data analytics solutions. Clients interact with the platform via contractual agreements, utilizing its various modules for insights into employee health data. This model supports scalable service delivery, enabling clients to access ongoing updates and relevant information as they grow, with pricing determined by the complexity of analytics required.Springbuk's future growth strategy includes the rollout of new product features aimed at enhancing the user experience, expected to launch in late 2024. The company plans to expand its services into new markets, specifically targeting regions in Europe and Asia by 2025. The recent funding of USD 17.00 mn will be utilized to support these initiatives, enhancing product development and market entry efforts.

## Funding rounds

- Series B, Jan 22, 2018, $20M — Elevate Ventures, HealthQuest Capital, Lewis & Clark Ventures, Echo Health Ventures
- Series A, May 19, 2016, $3.8M — Lewis & Clark Ventures

## Investors

- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series A, Series B
- Elevate Ventures (https://capitalatlas.ai/funds/elevate-ventures) — Series B
- HealthQuest Capital (https://capitalatlas.ai/funds/healthquest-capital) — Series B
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series B